Attached files
Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
The
undersigned, Tannya L. Irizarry, the Interim Chief Financial
Officer of GeneThera, Inc. (the “Company”), DOES HEREBY
CERTIFY that:
1.
The Company’s Annual Report on Form 10-K for the fiscal year
ended December 31, 2018 (the “Report”), fully complies
with the requirements of Section 13(a) of the Securities Exchange
Act of 1934; and
2.
Information contained in the Report fairly presents, in all
material respects, the financial condition and results of operation
of the Company.
IN
WITNESS WHEREOF, the undersigned has executed this statement this
27th day of February, 2020.
|
/s/ Tannya L.
Irizarry
|
|
Tannya
L. Irizarry
Interim
Chief Financial Officer
(Principal Financial and Accounting Officer)
|
A
signed original of this written statement required by Section 906
has been provided to GeneThera, Inc. and will be retained by
GeneThera, Inc. and furnished to the Securities and Exchange
Commission or its staff upon request.
The
foregoing certification is being furnished to the Securities and
Exchange Commission pursuant to § 18 U.S.C. Section 1350. It
is not being filed for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, and is not to be incorporated by
reference into any filing of the Company, whether made before or
after the date hereof, regardless of any general incorporation
language in such filing.